Since the original descriptions of """"""""putrefaction"""""""" by Hippocrates, sepsis has been recognized as a major cause of human suffering and mortality. Despite major advances made in understanding the systemic inflammatory response to infection, clinical trials of sepsis therapeutics have been repeatedly disappointing. These failure highlight the need for new, multidisciplinary perspectives into the onset, progression, and resolution of septic organ injury. The endothelial glycocalyx is a layer of glycosaminoglycans and associated proteoglycans lining the vascular surface. In vivo, the glycocalyx forms a substantial endothelial surface layer (ESL) that influences inflammation, endothelial permeability, and vascular tone-biologic processes highly relevant to sepsis pathophysiology. We have recently identified that the pulmonary ESL, by regulating exposure of endothelial surface adhesion molecules, serves a gatekeeping function controlling neutrophil transit into the lung. In response to an infectious stimulus, activated endothelial cells cleave the pulmonary ESL, allowing neutrophil adhesion and subsequent extravasation. Teleologically, this gatekeeping function would additionally require precise cellular control of ESL reconstitution, thereby limiting the magnitude of pulmonary inflammation. These processes of ESL repair, despite therapeutic relevance to patients with sepsis, have been unexplored. We hypothesize that a degraded pulmonary ESL is rapidly reconstituted in otherwise-healthy mice, allowing for maintenance of pulmonary vascular homeostasis. During sepsis, ESL reconstitution is delayed, contributing to the excessive pulmonary inflammation and edema characteristic of septic lung injury. Using state-of-the-art pulmonary intravital microscopy (E. Schmidt, Pulmonary/Critical Care, University of Colorado) and glycomic (R. Linhardt, Chemistry, Rensselaer Polytechnic Institute) approaches, we propose to (1) determine the mechanisms underlying pulmonary ESL reconstitution, (2) identify how these mechanisms are suppressed during sepsis, and (3) therapeutically manipulate these mechanisms to accelerate ESL reconstitution and attenuate septic lung injury. These multidisciplinary investigations, representing a highly novel collaboration within the field of sepsis, will be complemented by animal models of septic lung injury as well as analyses of biologic samples obtained from humans with severe sepsis. In summary, this proposal offers a new, multidisciplinary perspective on sepsis: that ESL integrity is a critical determinant of the onset and progression of septic organ injury. Investigating processes of ESL reconstitution may therefore identify novel therapeutic targets in a critical illness that, despite millennia of study, still lacks a clinically-efficacious, pathophysiology-targeted treatment.

Public Health Relevance

Sepsis is a common, severe condition caused by the body's response to an overwhelming infection. Sepsis can cause harm to people by damaging an important layer of sugars that lines blood vessels in the lungs. We are studying how this damaged layer of sugars can be repaired, so that we can find a new, effective treatment for sepsis.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-O (S1))
Program Officer
Sarkar, Rita
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Fox, Jamie C; Tyler, Robert C; Peterson, Francis C et al. (2016) Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer. Biochemistry 55:1214-25
Schmidt, Eric P; Overdier, Katherine H; Sun, Xiaojun et al. (2016) Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 194:439-49
Schmidt, Eric P; Kuebler, Wolfgang M; Lee, Warren L et al. (2016) Adhesion Molecules: Master Controllers of the Circulatory System. Compr Physiol 6:945-73
Haeger, Sarah M; Yang, Yimu; Schmidt, Eric P (2016) Heparan Sulfate in the Developing, Healthy, and Injured Lung. Am J Respir Cell Mol Biol 55:5-11
Sun, Xiaojun; Lin, Lei; Liu, Xinyue et al. (2016) Capillary Electrophoresis-Mass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin. Anal Chem 88:1937-43
Colbert, James F; Schmidt, Eric P (2016) Endothelial and Microcirculatory Function and Dysfunction in Sepsis. Clin Chest Med 37:263-75
Zhang, Fuming; Lee, Kyung Bok; Linhardt, Robert J (2015) SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs. Biosensors (Basel) 5:500-12
Sun, Xiaojun; Li, Lingyun; Overdier, Katherine H et al. (2015) Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography-Tandem Mass Spectrometry. Anal Chem 87:6220-7
Li, Guoyun; Li, Lingyun; Xue, Changhu et al. (2015) Profiling pneumococcal type 3-derived oligosaccharides by high resolution liquid chromatography-tandem mass spectrometry. J Chromatogr A 1397:43-51
Farrán, Angeles; Cai, Chao; Sandoval, Manuel et al. (2015) Green solvents in carbohydrate chemistry: from raw materials to fine chemicals. Chem Rev 115:6811-53